RASSF1 and neoplasm: However, these results should be interpreted with caution: (i) public databases lack isoform-specific data for RASSF1A, the tumor-suppressive isoform confirmed in this study; and (ii) TCGA does not provide brain metastasis-specific clinical information, which may obscure survival differences due to population heterogeneity.